Zapata Computing [ZPTA] - Last Close: $2.50
A late Thursday Schedule 13G/A disclosure from Wolverine Asset Management revealed the fund had taken a position in Zapata Computing.
According to the filing, Wolverine’s position includes 76,789 shares of common stock, a minor position equaling less than a 0.1% ownership stake.
ZPTA is up 27.6% on more than 6.5 million shares traded in response to the news.
My Take: ZPTA is coming off a major pullback, but volume has begin to pick up in the past couple of days. It could be gearing up for a swing higher.
PaxMedica [PXMD] - Last Close: $0.4119
In yesterday’s aftermarket, this tiny biotech announced the achievement of a key milestone and the development of its PAX-101 drug candidate.
PaxMedica announced the completed execution of three pivotal registration batches of PAX-101, and it expects to submit a new drug application to the FDA in Q4 2024.
PXMD is a top gainer with a 148.1% gain on more than 16 million shares traded.
My Take: PXMD is getting a big boost from this news, but can it hold onto its gains? I imagine we’ll see a least a partial pullback before this move runs its course.
NextPlat [NXPL] - Last Close: $1.50
NextPlat posted record-beating revenues of $49.7 million on its full-year 2024 financial report in Thursday’s aftermarket, and shares are soaring in response.
The company’s full-year revenue figure marked a 22% increase from last year, and it improved its gross profit margin to 30% from 24% in 2022.
NXPL is up 64.9% on more than 15 million shares traded.
My Take: NXPL is making headway on sales, but a solid annual profit could still be a long way off.
Allarity Therapeutics [ALLR] - Last Close: $2.30
Micro-cap biotech Allarity Therapeutics filed a prospectus summary that increased the price of stock included in an upcoming offering.
Allarity said it has increased the price of offered shares from a max of $1.4 million to a max of $2.4 million.
ALLR is up 30.8% in the wake of the announcement, with 3 million shares traded in ahead of the opening bell.
My Take: ALLR is offering shares at a price of $8.56 per share, which is a big premium over its current price. Maybe the '‘Smart Money” knows something we dont.
